Suchergebnisse - "Daratumumab"

PubPharm (71)

1

Pomalidomide combinations are a safe and effective option after daratumumab failure

enthalten in: Journal of cancer research and clinical oncology | 2023

von Brioli, A. | Gengenbach, L. | Mancuso, K. | +9

2

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

enthalten in: Annals of hematology | 2023

von Stanulla, M. | Schewe, D. | Bornhauser, B. | +12

3

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

enthalten in: Cancer immunology immunotherapy | 2022

von Thangaraj, J. | Jung, S. | Vo, M. | +11

4

Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience

enthalten in: Annals of hematology | 2022

von Barbieri, E. | Maccaferri, M. | Leonardi, G. | +7

5

Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma

enthalten in: Advances in therapy | 2022

von He, J. | Berringer, H. | Heeg, B. | +8

6

Immunotherapy in AL Amyloidosis

enthalten in: Current treatment options in oncology | 2022

von Zhang, Y. | Comenzo, R.

7

Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment

enthalten in: International journal of hematology | 2022

von Matsue, K. | Sunami, K. | Matsumoto, M. | +8

8

Monoclonal antibody Daratumumab promotes macrophage-mediated anti-myeloma phagocytic activity via engaging FC gamma receptor and activation of macrophages

enthalten in: Molecular and cellular biochemistry | 2022

von Gao, Y. | Li, L. | Zheng, Y. | +3

9

Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany

enthalten in: Advances in therapy | 2022

von Steinmetz, H. | Singh, M. | Milce, J. | +4

10

Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy

enthalten in: Annals of hematology | 2021

von Hu, X. | Wu, C. | Cowan, J. | +2

1
2
3
4
5
6
7
8
Nächster »
[8]